-
Stocks in Asia-Pacific started the week higher. S&P/ASX 200 gains 0.3%, Kospi adds 1.9% and indices from China trade over 1% higher. Japanese stock exchanges were shut for holiday
-
DAX futures point to a flat opening of the European cash session
-
Sky News reports that Brexit deal is 95% agreed on but some differences remain (fisheries, governance and competition)
-
US Food and Drug Administration issued emergency approval for Regeneron coronavirus treatment. According to media reports, UK may approve Pfizer coronavirus vaccine this week
-
US will add 4 Chinese companies to Pentagon blacklist while addition of another 89 is being considered
-
United States reported over 200,000 new coronavirus cases on Friday, daily record for a single country
-
ECB Chief Economist Lane said that new restrictions will lead to a smaller drop in economic activity than restrictions from the first half of the year
-
Australian manufacturing PMI for November came in at 56.1 (prev. 54.2) while services gauge reached 54.9 (prev. 53.7)
-
Singapore GDP for Q3 came in at 9.2% QoQ (exp. 9.5% QoQ(
-
Broad gains can be spotted on commodity markets with agriculture, oil and precious metal gaining
-
NZD and AUD are top moving major currencies while USD and JPY lag the most. Most EM currencies gain against US dollar
Pandemic situation. United States reported over 200,000 new cases on Friday. Source: worldometers, XTB
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
